Early Life
Barbara Boehringer's life has been shaped by her family's legacy in the pharmaceutical industry. She is part of the Boehringer family, who founded Boehringer Ingelheim in 1885. The company began as a small factory producing ingredients for pharmacies.
Rise to Success
Boehringer Ingelheim has grown into a global pharmaceutical giant. The company's key areas of interest include respiratory diseases, metabolism, immunology, oncology, and diseases of the central nervous system. The company focuses on innovation and partnerships to treat diseases with high unmet medical needs.
Key Business Strategies
Boehringer Ingelheim is a privately-owned company, with the Boehringer, Liebrecht, and von Baumbach families as the owners. This allows the company to take a long-term approach in achieving breakthroughs. The company invests heavily in research and development, with approximately €6.2 billion invested in 2024. Boehringer Ingelheim operates globally with 146 subsidiaries and has a workforce of 54,500 employees.
Philanthropy
Information on Barbara Boehringer's specific philanthropic activities is not readily available in the search results.